| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13200* | 2021 |
| Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol DR Richardson, DJR Lane, EM Becker, MLH Huang, M Whitnall, ... Proceedings of the National Academy of Sciences 107 (24), 10775-10782, 2010 | 550 | 2010 |
| Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease DJR Lane, AM Merlot, MLH Huang, DH Bae, PJ Jansson, S Sahni, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (5), 1130-1144, 2015 | 373 | 2015 |
| Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling J Paluncic, Z Kovacevic, PJ Jansson, D Kalinowski, AM Merlot, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1863 (4), 770-784, 2016 | 222 | 2016 |
| Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant MLH Huang, EM Becker, M Whitnall, YS Rahmanto, P Ponka, ... Proceedings of the National Academy of Sciences 106 (38), 16381-16386, 2009 | 219 | 2009 |
| Hepcidin, the hormone of iron metabolism, is bound specifically to α-2-macroglobulin in blood G Peslova, J Petrak, K Kuzelova, I Hrdy, P Halada, PW Kuchel, S Soe-Lin, ... Blood, The Journal of the American Society of Hematology 113 (24), 6225-6236, 2009 | 202 | 2009 |
| Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics DS Kalinowski, C Stefani, S Toyokuni, T Ganz, GJ Anderson, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1863 (4), 727-748, 2016 | 141 | 2016 |
| Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics KC Park, L Fouani, PJ Jansson, D Wooi, S Sahni, DJR Lane, ... Metallomics 8 (9), 874-886, 2016 | 130 | 2016 |
| The role of the antioxidant response in mitochondrial dysfunction in degenerative diseases: cross-talk between antioxidant defense, autophagy, and apoptosis MLH Huang, S Chiang, DS Kalinowski, DH Bae, S Sahni, DR Richardson Oxidative Medicine and Cellular Longevity 2019, 2019 | 124 | 2019 |
| The role of NDRG1 in the pathology and potential treatment of human cancers DH Bae, PJ Jansson, ML Huang, Z Kovacevic, D Kalinowski, CS Lee, ... Journal of clinical pathology 66 (11), 911-917, 2013 | 118 | 2013 |
| Mitochondrial mayhem: the mitochondrion as a modulator of iron metabolism and its role in disease MLH Huang, DJR Lane, DR Richardson Antioxidants & redox signaling 15 (12), 3003-3019, 2011 | 106 | 2011 |
| Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia M Whitnall, YS Rahmanto, MLH Huang, F Saletta, HC Lok, L Gutiérrez, ... Proceedings of the National Academy of Sciences 109 (50), 20590-20595, 2012 | 93 | 2012 |
| Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies J Skoda, K Borankova, PJ Jansson, MLH Huang, R Veselska, ... Pharmacological research 139, 298-313, 2019 | 76 | 2019 |
| The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich’s ataxia DR Richardson, MLH Huang, M Whitnall, EM Becker, P Ponka, ... Journal of molecular medicine 88, 323-329, 2010 | 74 | 2010 |
| The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1 W Liu, F Yue, M Zheng, A Merlot, DH Bae, M Huang, D Lane, P Jansson, ... Oncotarget 6 (11), 8851, 2015 | 72 | 2015 |
| The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets W Liu, Z Kovacevic, Z Peng, R Jin, P Wang, F Yue, M Zheng, MLH Huang, ... Oncotarget 6 (34), 35522, 2015 | 67 | 2015 |
| Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia S Chiang, Z Kovacevic, S Sahni, DJR Lane, AM Merlot, DS Kalinowski, ... Clinical science 130 (11), 853-870, 2016 | 63 | 2016 |
| Fixing frataxin:‘ironing out’the metabolic defect in F riedreich's ataxia A Anzovino, DJR Lane, MLH Huang, DR Richardson British journal of pharmacology 171 (8), 2174-2190, 2014 | 63 | 2014 |
| Molecular alterations in a mouse cardiac model of Friedreich ataxia: an impaired Nrf2 response mediated via upregulation of Keap1 and activation of the Gsk3β axis A Anzovino, S Chiang, BE Brown, CL Hawkins, DR Richardson, ... The American journal of pathology 187 (12), 2858-2875, 2017 | 56 | 2017 |
| Targeting the metastasis suppressor, N-Myc downstream regulated gene-1, with novel di-2-pyridylketone thiosemicarbazones: Suppression of tumor cell migration and cell-collagen … X Wangpu, J Lu, R Xi, F Yue, S Sahni, KC Park, S Menezes, MLH Huang, ... Molecular pharmacology 89 (5), 521-540, 2016 | 56 | 2016 |
Sumit SahniUniversity of SydneyVerified email at sydney.edu.au
